For the Quarter Ending June 2026
Dexamethasone Sodium Phosphate Prices in North America
- In the United States, Dexamethasone Sodium Phosphate Price Index rose quarter-over-quarter in Q2 2026, driven by increasing production costs.
- Production costs increased, with PPI rising 5.5% and CPI 3.5% year-over-year in June 2026.
- Demand was supported by strong consumer spending, which rose 6.9% year-over-year in May 2026.
- The Dexamethasone Sodium Phosphate Price Forecast indicates continued upward pressure due to persistent inflationary trends in Q2 2026.
- Industrial production showed modest expansion, increasing 0.7% year-over-year in June 2026.
- A low unemployment rate of 4.2% in June 2026 supported demand by improving healthcare access.
- Robust natural gas inventories through Q2 2026 limited some upward energy cost pressures.
- Imports of pharmaceutical preparations into the US increased in May 2026, while exports decreased.
- Consumer confidence, at 91.2 in June 2026, indicated moderate optimism, influencing healthcare behavior.
Why did the price of Dexamethasone Sodium Phosphate change in June 2026 in North America?
- Producer Price Index (PPI) rose 5.5% year-over-year in June 2026, increasing raw material costs.
- Consumer Price Index (CPI) increased 3.5% year-over-year in June 2026, raising operational expenses.
- Strong consumer spending, up 6.9% year-over-year in May 2026, supported demand.
Dexamethasone Sodium Phosphate Prices in APAC
- In China, Dexamethasone Sodium Phosphate Price Index rose in Q2 2026, driven by a 4.1% year-on-year PPI increase in June 2026. The Average price of Dexamethasone Sodium Phosphate Price stood at USD 1399/MT FOB China
- Dexamethasone Sodium Phosphate production costs increased in Q2 2026, as methanol feedstock costs trended upward.
- Raw chemical material purchasing prices for Dexamethasone Sodium Phosphate production increased year-on-year in May and June 2026.
- Global Dexamethasone Sodium Phosphate supply faced challenges in Q2 2026 from methanol production disruptions and trade blockages.
- China's manufacturing index expanded in June 2026, with industrial production growing 5.3% year-on-year.
- Dexamethasone Sodium Phosphate demand was mixed in Q2 2026, with retail sales growing 1.0% year-on-year in June 2026.
- A 5.0% unemployment rate in June 2026 supported healthcare utilization, while CPI was 1.0% year-on-year.
- Government policy and R&D support for the pharmaceutical industry remained strong in 2026, fostering Dexamethasone Sodium Phosphate innovation.
Why did the price of Dexamethasone Sodium Phosphate change in June 2026 in APAC?
- Rising production costs were driven by a 4.1% year-on-year PPI increase in June 2026.
- Methanol feedstock costs rose in Q2 2026, exacerbated by trade flow disruptions.
- Low CPI (1.0%) and retail sales (1.0%) in June 2026 indicated subdued demand.
Dexamethasone Sodium Phosphate Prices in Europe
- In Germany, the Dexamethasone Sodium Phosphate Price Index rose quarter-over-quarter in Q2 2026, driven by increasing production costs.
- Production costs for Dexamethasone Sodium Phosphate increased, with producer prices for industrial products rising 2.2% in May 2026.
- The Consumer Price Index rose 2.3% year-over-year in June 2026, indicating higher input costs for manufacturing.
- Germany's Manufacturing Index contracted in June 2026, and industrial production was unchanged (0.0%) in May 2026, impacting supply.
- Demand for Dexamethasone Sodium Phosphate was sustained by rising chronic inflammatory conditions and oncology treatments in 2026.
- Retail sales increased 1.8% in May 2026, supporting healthcare spending and boosting Dexamethasone Sodium Phosphate demand.
- Elevated energy and raw material costs, including petroleum-derived products, pressured Dexamethasone Sodium Phosphate production in H1 2026.
- Supply chain disruptions intensified during H1 2026, affecting Dexamethasone Sodium Phosphate availability and production efficiency.
Why did the price of Dexamethasone Sodium Phosphate change in June 2026 in Europe?
- Producer prices for industrial products rose 2.2% in May 2026, increasing Dexamethasone Sodium Phosphate manufacturing expenses.
- Elevated energy and raw material costs, including petroleum-derived products, pressured Dexamethasone Sodium Phosphate production in H1 2026.
- Supply chain disruptions intensified during the first half of 2026, affecting Dexamethasone Sodium Phosphate availability.
For the Quarter Ending March 2026
Dexamethasone Sodium Phosphate Prices in North America
- In United States, the Dexamethasone Sodium Phosphate Price Index rose quarter-over-quarter in Q1 2026, driven by tightened domestic supply.
- The Dexamethasone Sodium Phosphate Price Index absorbed inflation as the Consumer Price Index increased 3.3% in March 2026.
- The Producer Price Index climbed 4.0% while industrial production grew a modest 0.7% year-over-year in March 2026.
- The Manufacturing Index expanded, retail sales grew 4.0%, and unemployment remained stable at 4.3% during March 2026.
- Consumer confidence reached 91.8 in March 2026, strongly supporting the Dexamethasone Sodium Phosphate Demand Outlook.
- Clinical demand surged and wholesaler inventories of injections tightened significantly across healthcare sectors throughout Q1 2026.
- Domestic supply tightened as major regional producers placed essential medication vials on backorder during Q1 2026.
- The Dexamethasone Sodium Phosphate Production Cost Trend weakened as industrial natural gas prices plummeted in February 2026.
- The Dexamethasone Sodium Phosphate Price Forecast indicated upward pressure due to depleted preservative-free stockpiles in February 2026.
Why did the price of Dexamethasone Sodium Phosphate change in March 2026 in North America?
- Clinical demand for injections surged while domestic supply tightened significantly across hospitals during Q1 2026.
- The Producer Price Index climbed 4.0% year-over-year in March 2026, elevating overall pharmaceutical manufacturing expenses.
- Wholesaler inventories tightened and stockpiles of preservative-free vials depleted rapidly across markets in February 2026.
Dexamethasone Sodium Phosphate Prices in APAC
- In China, the Dexamethasone Sodium Phosphate Price Index rose quarter-over-quarter in Q1 2026, driven by rising March 2026 production costs.
- The Dexamethasone Sodium Phosphate Demand Outlook strengthened as hospital procurement for therapies surged in February 2026.
- A 1.0% CPI increase in March 2026 supported steady downstream consumption, while 1.7% retail sales growth softened over-the-counter demand.
- The Dexamethasone Sodium Phosphate Production Cost Trend stabilized as diosgenin feedstock processing costs leveled off in March 2026.
- Industrial production grew 5.7% in March 2026, and the Manufacturing Index expanded, ensuring adequate bulk API supply.
- A 5.4% unemployment rate in March 2026 and a 91.6 consumer confidence index in February 2026 reduced discretionary healthcare spending.
- Export approvals for Dexamethasone Sodium Phosphate active pharmaceutical ingredients strengthened following World Health Organization prequalification in February 2026.
- A 0.5% PPI increase in March 2026 created cost-push pressures, influencing the Dexamethasone Sodium Phosphate Price Forecast upward.
Why did the price of Dexamethasone Sodium Phosphate change in March 2026 in APAC?
- Hospital procurement for severe inflammatory condition treatments surged in February 2026, driving strong pharmaceutical demand.
- A 0.5% PPI increase in March 2026 elevated procurement costs for essential chemical and steroidal precursors.
- World Health Organization prequalification in February 2026 strengthened export approvals and international pharmaceutical trade flows.
Dexamethasone Sodium Phosphate Prices in Europe
- In Germany, the Dexamethasone Sodium Phosphate Price Index rose quarter-over-quarter in Q1 2026, driven by precursor costs.
- The Dexamethasone Sodium Phosphate Production Cost Trend increased as acetone costs surged in March 2026.
- The Dexamethasone Sodium Phosphate Demand Outlook weakened as pharmaceutical industry output plummeted in January 2026.
- Consumer inflation rose 2.7% in March 2026, increasing operational costs for Dexamethasone Sodium Phosphate manufacturing.
- Producer prices declined 0.2% in March 2026, showing slightly eased upstream costs for basic chemical precursors.
- Stagnant industrial production at 0.0% in February 2026 reflected flat baseline activity for pharmaceutical manufacturing.
- Retail sales grew 0.7% in February 2026, supporting steady consumer purchasing power for pharmacy products.
- A stable 4.2% unemployment rate in February 2026 ensured continued healthcare access and steady prescription rates.
- Negative consumer confidence at -24.7 index in March 2026 lowered the Dexamethasone Sodium Phosphate Price Forecast.
Why did the price of Dexamethasone Sodium Phosphate change in March 2026 in Europe?
- European natural gas prices surged in March 2026, elevating energy costs for regional chemical production.
- Acetone precursor costs surged in March 2026, directly increasing pharmaceutical active ingredient synthesis production expenses.
- European petrochemical supply faced disruption concerns in March 2026, tightening regional availability of essential feedstocks.
For the Quarter Ending December 2025
Dexamethasone Sodium Phosphate Prices in North America
- In the United States, the Dexamethasone Sodium Phosphate Price Index rose quarter-over-quarter in Q4 2025, driven by increasing production costs.
- Dexamethasone Sodium Phosphate production costs increased during Q4 2025, influenced by gradually rising natural gas spot prices.
- Demand for Dexamethasone Sodium Phosphate was supported by an inching up of the prescription drugs index in December 2025.
- Overall industrial production grew 2.0% year-over-year in December 2025, indicating a robust supply chain environment.
- US business inventories increased in October 2025, while manufacturing inventories remained unchanged during that month.
- US imports of pharmaceutical preparations decreased in October 2025, impacting overall market supply dynamics.
- The Consumer Price Index rose 2.7% year-over-year in December 2025, contributing to higher operational expenses.
- The Producer Price Index increased 3.0% year-over-year in November 2025, reflecting elevated input costs for chemical production.
- The Dexamethasone Sodium Phosphate price forecast suggests continued upward pressure due to persistent energy cost increases in Q4 2025.
Why did the price of Dexamethasone Sodium Phosphate change in December 2025 in North America?
- Production costs rose due to gradually increasing natural gas spot prices in Q4 2025.
- Industrial electricity costs increased in November 2025, elevating manufacturing expenses.
- The prescription drugs index inched up in December 2025, supporting chemical demand.
Dexamethasone Sodium Phosphate Prices in APAC
- In China, the Dexamethasone Sodium Phosphate Price Index declined quarter-over-quarter in Q4 2025, influenced by falling producer input costs.
- Dexamethasone Sodium Phosphate production costs decreased in December 2025, as the Producer Price Index fell by -1.9% year-on-year.
- Overall Dexamethasone Sodium Phosphate demand softened during Q4 2025, reflecting weak consumer spending with retail sales growing only 0.9% in December 2025.
- The Dexamethasone Sodium Phosphate market experienced downward price pressure in Q4 2025 due to subdued consumer confidence.
- Industrial production expanded by 5.2% year-on-year in December 2025, supporting stable Dexamethasone Sodium Phosphate supply chain efficiency.
- China's Manufacturing Index expanded in December 2025, indicating improved operational conditions for Dexamethasone Sodium Phosphate manufacturers.
- Low Consumer Price Index growth of 0.8% in December 2025 suggested weak inflationary pressure on Dexamethasone Sodium Phosphate operational costs.
- A 5.1% urban unemployment rate in December 2025 indicated economic headwinds, indirectly impacting Dexamethasone Sodium Phosphate healthcare demand.
Why did the price of Dexamethasone Sodium Phosphate change in December 2025 in APAC?
- The Producer Price Index declined by -1.9% in December 2025, reducing Dexamethasone Sodium Phosphate manufacturing input costs.
- Weak consumer spending, with retail sales growing only 0.9% in December 2025, softened Dexamethasone Sodium Phosphate demand.
- Subdued consumer confidence in Q4 2025 contributed to overall bearish sentiment for Dexamethasone Sodium Phosphate prices.
Dexamethasone Sodium Phosphate Prices in Europe
- In Germany, the Dexamethasone Sodium Phosphate Price Index fell in Q4 2025, driven by decreasing producer costs.
- Dexamethasone Sodium Phosphate production costs declined in December 2025, as the Producer Price Index (PPI) fell 2.5% year-over-year.
- Overall demand for Dexamethasone Sodium Phosphate faced headwinds in December 2025 due to a contracting Manufacturing Index.
- Consumer confidence was significantly pessimistic at -17.5 in December 2025, indirectly impacting healthcare spending.
- Industrial production grew 0.8% in October 2025, supporting a stable supply chain for Dexamethasone Sodium Phosphate.
- Retail sales increased 1.1% in November 2025, indicating stable consumer spending, indirectly supporting healthcare.
- Moderate inflation, with CPI at 1.8% in December 2025, slightly increased pharmaceutical operational costs.
- The Dexamethasone Sodium Phosphate Price Index is forecast to remain stable in early 2026, balancing cost reductions and demand.
Why did the price of Dexamethasone Sodium Phosphate change in December 2025 in Germany?
- Producer costs for Dexamethasone Sodium Phosphate declined due to a 2.5% decrease in PPI in December 2025.
- Contracting Manufacturing Index in December 2025 indicated slower economic activity, dampening demand.
- Pessimistic consumer confidence at -17.5 in December 2025 indirectly reduced healthcare spending.
For the Quarter Ending September 2025
Dexamethasone Sodium Phosphate Prices in North America
- In United States, the Dexamethasone Sodium Phosphate Price Index rose in Q3 2025, driven by rising costs and robust healthcare demand.
- Production costs increased, with CPI up 3.0% (September 2025) and PPI up 2.6% (August 2025).
- Demand outlook remained strong, supported by 5.42% retail sales growth and 4.3% unemployment in September 2025.
- Raw materials inventory levels contracted in Q3 2025, indicating tightening Dexamethasone Sodium Phosphate supply.
- Industrial electricity prices increased in August 2025, raising Dexamethasone Sodium Phosphate manufacturing expenses.
- US natural gas prices showed an uptick during Q3 2025, impacting Dexamethasone Sodium Phosphate production costs.
- US healthcare spending is projected to increase in 2025, bolstering Dexamethasone Sodium Phosphate demand.
- The Dexamethasone Sodium Phosphate Price Index is forecast to remain firm due to persistent cost pressures.
Why did the price of Dexamethasone Sodium Phosphate change in September 2025 in North America?
- Rising input costs, evidenced by 3.0% CPI increase in September 2025, elevated production expenses.
- Strong consumer spending, with retail sales up 5.42% in September 2025, supported pharmaceutical demand.
- Contracted raw materials inventory levels in Q3 2025 contributed to tighter Dexamethasone Sodium Phosphate supply.
Dexamethasone Sodium Phosphate Prices in APAC
- In China, the Dexamethasone Sodium Phosphate Price Index fell quarter-over-quarter in Q3 2025, influenced by declining producer prices.
- Production costs decreased as the Producer Price Index fell by 2.3% in September 2025, impacting raw material expenses.
- Demand for Dexamethasone Sodium Phosphate strengthened in Q3 2025, driven by an aging population and chronic disease prevalence.
- The Manufacturing Index was contracting in September 2025, indicating a slowdown in industrial activity and potential supply chain disruptions.
- Industrial production grew by 6.5% year-on-year in September 2025, supporting a stable supply of necessary raw materials.
- Overall chemical overcapacity intensified in 2025, with high inventories contributing to downward price pressure in Q3 2025.
- Consumer confidence remained pessimistic at 89.6 in September 2025, with CPI falling 0.3%, dampening overall healthcare spending.
- Pharmaceutical exports from Shanghai surged in Q1-Q3 2025, partially offsetting soft domestic Dexamethasone Sodium Phosphate demand.
Why did the price of Dexamethasone Sodium Phosphate change in September 2025 in APAC?
- Producer prices declined by 2.3% in September 2025, directly reducing Dexamethasone Sodium Phosphate manufacturing costs.
- Global chemical overcapacity intensified in 2025, leading to high inventories and downward price pressure.
- Soft domestic consumer demand, with 3.0% retail sales growth, and contracting manufacturing activity contributed to price declines.
Dexamethasone Sodium Phosphate Prices in Europe
- In Germany, Dexamethasone Sodium Phosphate Price Index rose in Q3 2025, driven by surging API prices.
- Production costs faced upward pressure from a 2.4% CPI increase in September 2025, reflecting inflation.
- A 1.7% PPI decline in September 2025, due to lower energy prices, partially mitigated production costs.
- The Manufacturing Index contracted in Q3 2025, signaling industrial slowdown and demand constraints.
- Dexamethasone Sodium Phosphate demand was impacted by a 1.0% industrial production decline in September 2025.
- Natural gas prices in Germany moderated in Q3 2025, showing a downward trend, easing energy costs.
- API prices surged in July 2025 due to logistical issues, increasing raw material expenses.
- Germany's chemical and pharmaceutical industry production declined in Q3 2025, alongside reduced international sales.
- Modest 0.2% retail sales growth and stabilizing consumer confidence in Q3 2025 offered demand support.
- A 6.3% unemployment rate in September 2025 indicated economic weakness, limiting healthcare spending.
Why did the price of Dexamethasone Sodium Phosphate change in September 2025 in Europe?
- API prices surged in September 2025 due to logistical issues, increasing Dexamethasone Sodium Phosphate input costs.
- A 2.4% CPI increase in September 2025 raised overall manufacturing and distribution expenses.
- Moderating natural gas prices in Q3 2025 partially offset cost pressures, but overall costs rose.
